Brazil farmers, Syngenta blast restrictions on use of popular insecticide
By Roberto Samora
SAO PAULO, Feb 28 (Reuters) -A decision by Brazilian environmental agency Ibama to restrict the use of the widely popular thiamethoxam insecticide has attracted criticism from farmers and makers of the product, which is seen as toxic for bees and other pollinators.
After a public consultation, Ibama decided thiamethoxam may no longer be sprayed by tractors or agricultural planes. Its use is still authorized for seed treatment and to prepare land for planting.
Limiting use of thiamethoxam will cut yields and leave farmers with only a few options to control pests, according to Lucas Beber, head of Mato Grosso state farmer group Aprosoja-MT.
Syngenta, which developed thiamethoxam and was the first to register it in Brazil, claims the product is safe for all types of applications. The company noted "it is taking appropriate administrative and judicial measures aimed at mitigating damage to Brazilian farmers."
Aprosoja's Beber said even if there were alternatives to thiamethoxam, insecticide prices will rise, harming big and small farmers.
"Responsible use (of thiamethoxam) does not pose a danger
for bees," Beber said.
In a statement issued after restrictions were announced last Friday, Brazil's Environment Ministry and Ibama stated that thiamethoxam's environmental reassessment process is based on scientific evidence and expert opinion.
According to the agencies, thiamethoxam has been restricted or banned in other countries due to its impact on bees and other pollinators.
Syngenta criticized the restrictions and the fact they were imposed without the involvement of Brazil's Agriculture Ministry.
The company said thiamethoxam is essential for crops such as corn, soybeans, cotton, sugar cane, coffee, rice and oranges, adding it is registered for use in more than 80 countries, including Argentina, Australia, Canada, China, United States, Japan and Mexico.
Ibama and the Agriculture Ministry did not immediately comment on Syngenta's criticism of restrictions.
Reporting by Roberto Samora
Writing by Ana Mano; Editing by Chizu Nomiyama
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
